The Future of the Pharmaceutical World

Major and local pharma companies, CMOs, CDMOs, service and equipment providers gather at the Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to discuss new technologies and ongoing trends, as well as to establish business connections. The Congress takes place in Berlin, Germany, on April, 14-15, 2025.

PHARMAP is a networking event which annually brings over more than 300 leaders of the whole pharma industry. The participants can see innovations shown at the focus exhibition and enjoy thought-provoking discussions by the key players. Since 2021, the Congress has welcomed over 1,000 delegates and this year celebrates its 5th anniversary.

Annually, the Congress addresses challenges in the pharmaceutical sector, including manufacturing optimization and digitalization, supply chain disruptions, anti-counterfeiting measures and advancements in smart packaging. In 2025, the agenda expands to include discussions on pharmaceutical facility design and layout with Bayer presenting its innovative approaches in technology, design and execution. Besides those topics, the congress covers these themes:

  • Green initiatives and integration of sustainability;
  • Outsourcing and contract manufacturing;
  • Advancements in packaging technologies and labeling;
  • Pharma quality assurance.

The questions being brought up at the congress are valuable for the future of the pharmaceutical world, as well as the connections that companies form with each other to work together on projects that are advancing the industry. The sessions, round tables, coffee breaks and anniversary gala dinner - all activities are great for collaboration.

Join PHARMAP 2025 by visiting the website: https://sh.bgs.group/26i

Company

BGS Group



Netherlands

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.